查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2024188

全球新冠病毒診斷市場：各國市場- 面向高管和顧問的指南（2026-2030 年）

COVID-19 Diagnostics. Global C19 Diagnostic Market Forecast by Technology, Product, Channel and Country. With Executive and Consultant Guides. 2026-2030
出版日期: | 出版商: Howe Sound Research | 英文 417 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

報告摘要：

疫情或許已經結束，但新冠病毒仍將存在。眾多競爭者正在爭奪呼吸系統診斷領域這個盈利豐厚的未來市場。

基於感染疾病疫情，診斷市場正在湧現一個充滿活力的新興市場。檢測方式正從診所轉向家庭。唾液檢測？攜帶式多重檢測設備？家用檢測套組？在安全至關重要的職場場所，檢測市場又將如何發展？而為因應疫情而建立的大規模檢測系統，在需求下降的情況下，又將何去何從？欲了解更多關於這些不斷變化的市場的信息，請閱讀我們的最新報告。

銷售、技術、產品和銷售管道—本報告涵蓋所有這些方面，並按國家和地區提供詳細分類。利用我們的市場指南和情勢分析，快速掌握市場動態。

所有報告資料均可應要求以Excel格式提供。利用最新數據做出更準確的預測。

目錄

第1章 市集指南

  • 戰略態勢分析
  • 高階主管指南
  • 管理諮詢顧問和投資顧問指南

第2章：引言與市場定義

  • 什麼是大流行病？
  • 通用感染疾病的作用
  • 市場定義
    • PCR
    • 多重PCR
    • SEQ
    • 抗原
    • 抗體
    • 裝置
    • 試劑和試劑盒
    • 提煉
    • 收集
    • 民眾
    • 醫院
    • 診所
    • 職場
    • DTC/OTC
    • 污水
  • 調查方法
    • 資訊來源
    • 作者
  • 從歷史觀點看大流行病
    • 愛滋病大流行（2005-2012 年）
    • 流感大流行（1968 年）
    • 亞洲流感（1956-1958）
    • 西班牙流感（1918）
    • 第六次霍亂疫情（1910-1911年）
    • 流感大流行（1889-1890）
    • 黑死病（1346-1353年）

第3章：疫情概述

  • 什麼是病毒？
  • 新冠病毒
  • 大流行診斷

第4章 產業結構

  • 參與企業充滿活力的市場
    • 學術研究辦公室
    • 診斷測試開發人員
    • 測量儀器供應商
    • 化學品/試劑供應商
    • 病理檢測用品供應商
    • 獨立臨床實驗室
    • 國家/地區公共研究機構
    • 醫院檢查室
    • 醫師診所檢查室(POLS)
    • 審計機構
    • 認證機構

第5章：診斷相關企業概況

  • Advanced Biological Laboratories
  • Abbott Laboratories
  • Accel Diagnostics
  • Accelerate Diagnostics
  • Access Bio
  • ADT Biotech
  • Agilent
  • Altona Diagnostics
  • Alveo Technologies
  • Anatolia Geneworks
  • Anitoa
  • Applied BioCode
  • Applied DNA Sciences
  • Aureum Diagnostics
  • Aurora Biomed
  • Aus Diagnostics
  • Autobio Diagnostics
  • Autonomous Medical Devices
  • Beckman Coulter Diagnostics (Danaher)
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • BillionToOne
  • Binx Health
  • Biocartis
  • Biodesix Inc.
  • BioFire Diagnostics (bioMerieux)
  • BioGX
  • Biolidics Ltd
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Reference Laboratories
  • Boditech Med, Inc
  • Bosch Healthcare Solutions GmbH
  • Celemics
  • Cepheid (Danaher)
  • Cerstest Biotec
  • Chembio
  • Co Diagnostics
  • Color Genomics
  • CTK Biotech
  • Cube Dx
  • Cue Health
  • Curetis (OpGen)
  • Detect
  • Diagenode Diagnostics (Hologic)
  • Diasorin SpA
  • Domus Diagnostics
  • Ellume
  • Enzo Biochem
  • Everywell
  • Fluxergy
  • Fujirebio
  • Fulgent Genetics
  • Fusion Genomics.
  • Fyr Diagnostics
  • Genedrive
  • Genetic Signatures
  • GenMark Dx (Roche)
  • Genomadix
  • Gold Standard Diagnostics
  • Hologic
  • Illumina
  • Immunexpress
  • Inflammatix
  • Innova Medical Group
  • J&J Innovative Medicine
  • Karius
  • Laboratory Corporation of America
  • Letsgetchecked
  • LightDeck Diagnostics
  • LumiraDx
  • Mammoth Biosciences
  • Mayo Clinic Laboratories
  • Meep
  • Meridian Bioscience
  • Mesa Laboratories, Inc.
  • Molbio Diagnostics
  • NanoDx
  • Nanomix
  • Novacyt
  • Nuclein
  • OnsiteGene
  • OraSure Technologies
  • Oxford Nanopore Technologies
  • Prenetics
  • Primerdesign (Novacyt)
  • Prominex
  • Proof Diagnostics
  • Qiagen
  • QuantuMDx
  • Quest Diagnostics
  • QuidelOrtho
  • Randox Toxicology
  • R-Biopharm AG
  • Revvity
  • Roche Diagnostics
  • Salignostics
  • Scope Fluidics
  • SD Biosensor
  • Seegene
  • Sekisui Diagnostics
  • Sherlock Biosciences
  • Siemens Healthineers
  • Singular Genomics
  • Sona Nanotech
  • SpeeDx
  • Standard BioTools
  • Streamline Scientific
  • Talis Biomedical
  • Thermo Fisher Scientific
  • Ultima Genomics
  • Uniogen
  • Vela Diagnostics
  • Veredus Laboratories
  • Vircell
  • Visby Medical
  • Wantai Biopharm
  • YD Diagnostics
  • Zhejiang Orient Gene Biotech

第6章：新冠肺炎診斷的最新趨勢

第7章：全球新冠病毒診斷市場

  • 全球市場各國概覽
  • 全球市場概覽（依技術分類）
  • 全球市場概覽（按產品類別分類）
  • 全球市場概覽（按通路分類）

第8章：全球新冠病毒診斷市場－依技術分類

  • PCR
  • 多重PCR
  • 序列分析
  • 抗體
  • 抗原

第9章：全球新冠病毒診斷市場－按產品分類

  • 裝置
  • 試劑和試劑盒
  • 萃取
  • 收藏

第10章：全球新冠病毒診斷市場－按通路分類

  • 民眾
  • 醫院
  • 診所
  • 職場
  • DTC/OTC
  • 污水

第11章附錄

表格一覽

圖表列表

簡介目錄
Product Code: COVID 19 Dx 426

Report Overview:

The pandemic may be over but Covid-19 is here to stay. Multiple competitors are vying for the very lucrative future for respiratory diagnostics.

A new dynamic market is emerging for Covid - 19 based diagnostics. Testing is moving into physicians' offices and even into the home. Saliva tests? Handheld multiplex testers? Home based testing sticks? And what about the Workplace market where safety is paramount? And what happens to the large laboratory capacity that was built up to handle a pandemic now in decline? Learn all about these changing markets in our latest report.

Revenue, technology, products and channels. They are all looked at in this complete report that provides detailed breakdowns by country and regions. Get on top of the situation quickly with our Market Guides and Situation Analysis.

All report data is available in Excel format on request. Make projections with confidence using the latest data.

Table of Contents

1 Market Guides

  • 1.1 Strategic Situation Analysis
  • 1.2 Guidance for Executives
  • 1.3 Guidance for Management Consultants and Investment Advisors

2 Introduction and Market Definition

  • 2.1 What are Pandemics?
  • 2.2 The Role of Zoonosis
  • 2.3 Market Definition
    • 2.3.1 PCR
    • 2.3.2 PCR Multiplex
    • 2.3.3 SEQ
    • 2.3.4 Antigen
    • 2.3.5 Antibodies
    • 2.3.6 Instruments
    • 2.3.7 Reagents and Kits
    • 2.3.8 Extract
    • 2.3.9 Collect
    • 2.3.10 Public
    • 2.3.11 Hospital
    • 2.3.12 Clinic
    • 2.3.13 Workplace
    • 2.3.14 DTC/OTC
    • 2.3.15 Wastewater
  • 2.4 Methodology
    • 2.4.1 Sources
    • 2.4.2 Authors
  • 2.5 Historical Perspective on Pandemics
    • 2.5.1 HIV/AIDS PANDEMIC 2005-2012
    • 2.5.2 FLU PANDEMIC 1968
    • 2.5.3 ASIAN FLU 1956-1958
    • 2.5.4 SPANISH FLU 1918
    • 2.5.5 SIXTH CHOLERA PANDEMIC 1910-1911
    • 2.5.6 FLU PANDEMIC 1889-1890
    • 2.5.7 THE BLACK DEATH 1346-1353

3 The Pandemic Overview

  • 3.1 What is a Virus?
    • 3.1.1 Is a Virus Alive?
    • 3.1.2 Viral Structure
    • 3.1.3 The Viral Genome
    • 3.1.4 Viral Mutation
  • 3.2 The Coronavirus
    • 3.2.1 Severe acute respiratory syndrome (SARS)
    • 3.2.2 Middle East respiratory syndrome (MERS)
    • 3.2.3 COVID-19. The SARS CoV 2 Virus.
      • 3.2.3.1 Signs and symptoms
      • 3.2.3.2 Transmission
      • 3.2.3.3 Diagnosis
      • 3.2.3.4 Prevention
      • 3.2.3.5 Management
      • 3.2.3.6 Prognosis
      • 3.2.3.7 A Note on Global Statistics Reporting
  • 3.3 Pandemic Diagnostics
    • 3.3.1 Risk Management - Spark and Spread
    • 3.3.2 Dx Technology - Nucleic Acid Based
    • 3.3.3 Dx Technology - Immunoassay
    • 3.3.4 Time to Market and Preparedness Issues

4 Industry Structure

  • 4.1 Players in a Dynamic Market
    • 4.1.1 Academic Research Lab
    • 4.1.2 Diagnostic Test Developer
    • 4.1.3 Instrumentation Supplier
    • 4.1.4 Chemical/Reagent Supplier
    • 4.1.5 Pathology Supplier
    • 4.1.6 Independent Clinical Laboratory
    • 4.1.7 Public National/regional Laboratory
    • 4.1.8 Hospital Laboratory
    • 4.1.9 Physicians Office Lab (POLS)
    • 4.1.10 Audit Body
    • 4.1.11 Certification Body

5 Diagnostic Company Profiles

  • 5.1 Advanced Biological Laboratories
  • 5.2 Abbott Laboratories
  • 5.3 Accel Diagnostics
  • 5.4 Accelerate Diagnostics
  • 5.5 Access Bio
  • 5.6 ADT Biotech
  • 5.7 Agilent
  • 5.8 Altona Diagnostics
  • 5.9 Alveo Technologies
  • 5.10 Anatolia Geneworks
  • 5.11 Anitoa
  • 5.12 Applied BioCode
  • 5.13 Applied DNA Sciences
  • 5.14 Aureum Diagnostics
  • 5.15 Aurora Biomed
  • 5.16 Aus Diagnostics
  • 5.17 Autobio Diagnostics
  • 5.18 Autonomous Medical Devices
  • 5.19 Beckman Coulter Diagnostics (Danaher)
  • 5.20 Becton, Dickinson and Company
  • 5.21 BGI Genomics Co. Ltd
  • 5.22 BillionToOne
  • 5.23 Binx Health
  • 5.24 Biocartis
  • 5.25 Biodesix Inc.
  • 5.26 BioFire Diagnostics (bioMerieux)
  • 5.27 BioGX
  • 5.28 Biolidics Ltd
  • 5.29 bioMerieux Diagnostics
  • 5.30 Bioneer Corporation
  • 5.31 Bio-Rad Laboratories, Inc
  • 5.32 Bio-Reference Laboratories
  • 5.33 Boditech Med, Inc
  • 5.34 Bosch Healthcare Solutions GmbH
  • 5.35 Celemics
  • 5.36 Cepheid (Danaher)
  • 5.37 Cerstest Biotec
  • 5.38 Chembio
  • 5.39 Co Diagnostics
  • 5.40 Color Genomics
  • 5.41 CTK Biotech
  • 5.42 Cube Dx
  • 5.43 Cue Health
  • 5.44 Curetis (OpGen)
  • 5.45 Detect
  • 5.46 Diagenode Diagnostics (Hologic)
  • 5.47 Diasorin S.p.A.
  • 5.48 Domus Diagnostics
  • 5.49 Ellume
  • 5.50 Enzo Biochem
  • 5.51 Everywell
  • 5.52 Fluxergy
  • 5.53 Fujirebio
  • 5.54 Fulgent Genetics
  • 5.55 Fusion Genomics.
  • 5.56 Fyr Diagnostics
  • 5.57 Genedrive
  • 5.58 Genetic Signatures
  • 5.59 GenMark Dx (Roche)
  • 5.60 Genomadix
  • 5.61 Gold Standard Diagnostics
  • 5.62 Hologic
  • 5.63 Illumina
  • 5.64 Immunexpress
  • 5.65 Inflammatix
  • 5.66 Innova Medical Group
  • 5.67 J&J Innovative Medicine
  • 5.68 Karius
  • 5.69 Laboratory Corporation of America
  • 5.70 Letsgetchecked
  • 5.71 LightDeck Diagnostics
  • 5.72 LumiraDx
  • 5.73 Mammoth Biosciences
  • 5.74 Mayo Clinic Laboratories
  • 5.75 Meep
  • 5.76 Meridian Bioscience
  • 5.77 Mesa Laboratories, Inc.
  • 5.78 Molbio Diagnostics
  • 5.79 NanoDx
  • 5.80 Nanomix
  • 5.81 Novacyt
  • 5.82 Nuclein
  • 5.83 OnsiteGene
  • 5.84 OraSure Technologies
  • 5.85 Oxford Nanopore Technologies
  • 5.86 Prenetics
  • 5.87 Primerdesign (Novacyt)
  • 5.88 Prominex
  • 5.89 Proof Diagnostics
  • 5.90 Qiagen
  • 5.91 QuantuMDx
  • 5.92 Quest Diagnostics
  • 5.93 QuidelOrtho
  • 5.94 Randox Toxicology
  • 5.95 R-Biopharm AG
  • 5.96 Revvity
  • 5.97 Roche Diagnostics
  • 5.98 Salignostics
  • 5.99 Scope Fluidics
  • 5.100 SD Biosensor
  • 5.101 Seegene
  • 5.102 Sekisui Diagnostics
  • 5.103 Sherlock Biosciences
  • 5.104 Siemens Healthineers
  • 5.105 Singular Genomics
  • 5.106 Sona Nanotech
  • 5.107 SpeeDx
  • 5.108 Standard BioTools
  • 5.109 Streamline Scientific
  • 5.110 Talis Biomedical
  • 5.111 Thermo Fisher Scientific
  • 5.112 Ultima Genomics
  • 5.113 Uniogen
  • 5.114 Vela Diagnostics
  • 5.115 Veredus Laboratories
  • 5.116 Vircell
  • 5.117 Visby Medical
  • 5.118 Wantai Biopharm
  • 5.119 YD Diagnostics
  • 5.120 Zhejiang Orient Gene Biotech

6 Covid-19 Diagnostics Recent Developments

  • 6.1 Recent Developments - Importance and How to Use This Section
    • 6.1.1 Importance of These Developments
    • 6.1.2 How to Use This Section
  • 6.2 SEKISUI DX to Provide C19/Flu Test to the POC and Home Markets
  • 6.3 Co-Diagnostics Submit Enhanced C19 Test
  • 6.4 AI Blood Test Detects Long COVID with 93% Accuracy
  • 6.5 Roche Diagnostics Growth Offset by COVID Sales Declines
  • 6.6 Credo Preps MDx System, Multiplex Respiratory Test for US Launch
  • 6.7 Acon Laboratories Gets FDA EAU for OTC COVID, Flu Test
  • 6.8 Impact of Long COVID Revealed
  • 6.9 QuidelOrtho Receives Clearance for Home COVID-19 Test
  • 6.10 SEKISUI Dx Receives EAU for the OSOMR Flu SARS-CoV-2 Combo Test
  • 6.11 Johns Hopkins Shows COVID-19 Tests Done at Home Are Reliable
  • 6.12 Walgreens Offers COVID-19 and Flu Testing
  • 6.13 Home Test to Treat program extends nationwide
  • 6.14 New test for long COVID Possible
  • 6.15 Labcorp Gets Approval for Sequencing-Based COVID Test
  • 6.16 Post-Pandemic, Patients Savvy About ID Diagnostics
  • 6.17 Discover Labs Obtains EUA for RT-PCR COVID Test
  • 6.18 Sensible Dx to Launch 10-Minute POC PCR System
  • 6.19 Aptitude Medical Systems Aiming for At-Home Market
  • 6.20 Qorvo To Emerge as More Than a COVID Company
  • 6.21 End of COVID-19 Emergency Lowers Diagnostics Revenue
  • 6.22 FDA Issues EUA for GenBody At-Home COVID Test
  • 6.23 CTK Biotech Gets EAU for At-Home COVID Antigen Test
  • 6.24 FDA Grants EAU for Premier Medical At-Home COVID Assay
  • 6.25 QuidelOrtho Seeks Home Testing Contract
  • 6.26 Aptitude Medical Gets EUA for Over-the-Counter COVID Saliva MDx
  • 6.27 Siemens Healthineers Gains CE Marks for Seasonal Viral Assays
  • 6.28 NanoDx Prepares for POC Platform Commercialization With TBI, COVID Tests
  • 6.29 North American Dx Recalls Covid Rapid Antigen Tests
  • 6.30 Domus Dx to Launch OC Diagnostics Test System
  • 6.31 Becton Dickinson, ReturnSafe Collaborate on COVID-19 Testing
  • 6.32 Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA
  • 6.33 At-Home COVID Test Coverage
  • 6.34 LuminUltra Wins 500-Site CDC Wastewater Testing Contract
  • 6.35 Sense Biodetection to Debut Instrument-Free Point-of-Care MDx
  • 6.36 Tests Called Back

7 The Global Market for COVID-19 Diagnostics

  • 7.1 Global Market Overview by Country
    • 7.1.1 Table - Global Market by Country
    • 7.1.2 Chart - Global Market by Country
  • 7.2 Global Market by Technology - Overview
    • 7.2.1 Table - Global Market by Technology
    • 7.2.2 Chart - Global Market by Technology - Base/Final Year Comparison
    • 7.2.3 Chart - Global Market by Technology - Base Year
    • 7.2.4 Chart - Global Market by Technology - End Year
    • 7.2.5 Chart - Global Market by Technology - Share by Year
    • 7.2.6 Chart - Global Market by Technology - Segments Growth
  • 7.3 Global Market by Product - Overview
    • 7.3.1 Table - Global Market by Product
    • 7.3.2 Chart - Global Market by Product - Base/Final Year Comparison
    • 7.3.3 Chart - Global Market by Product - Base Year
    • 7.3.4 Chart - Global Market by Product - End Year
    • 7.3.5 Chart - Global Market by Product - Share by Year
    • 7.3.6 Chart - Global Market by Product - Segments Growth
  • 7.4 Global Market by Channel - Overview
    • 7.4.1 Table - Global Market by Channel
    • 7.4.2 Chart - Global Market by Channel - Base/Final Year Comparison
    • 7.4.3 Chart - Global Market by Channel - Base Year
    • 7.4.4 Chart - Global Market by Channel - End Year
    • 7.4.5 Chart - Global Market by Channel - Share by Year
    • 7.4.6 Chart - Global Market by Channel - Segments Growth

8 Global COVID-19 Diagnostic Markets - By Technology

  • 8.1 PCR
    • 8.1.1 Table PCR - by Country
    • 8.1.2 Chart - PCR Growth
  • 8.2 PCR Multiplex
    • 8.2.1 Table PCR Multiplex - by Country
    • 8.2.2 Chart - PCR Multiplex Growth
  • 8.3 Sequencing
    • 8.3.1 Table Sequencing - by Country
    • 8.3.2 Chart - Sequencing Growth
  • 8.4 Antibody
    • 8.4.1 Table Antibody - by Country
    • 8.4.2 Chart - Antibody Growth
  • 8.5 Antigen
    • 8.5.1 Table Antigen - by Country
    • 8.5.2 Chart - Antigen Growth

9 Global COVID-19 Diagnostic Markets - By Product

  • 9.1 Instruments
    • 9.1.1 Table Instruments - by Country
    • 9.1.2 Chart - Instruments Growth
  • 9.2 Reagents & Kits
    • 9.2.1 Table Reagents & Kits - by Country
    • 9.2.2 Chart - Reagents & Kits Growth
  • 9.3 Extraction
    • 9.3.1 Table Extraction - by Country
    • 9.3.2 Chart - Extraction Growth
  • 9.4 Collection
    • 9.4.1 Table Collection - by Country
    • 9.4.2 Chart - Collection Growth

10 Global COVID-19 Diagnostic Markets - By Channel

  • 10.1 Public
    • 10.1.1 Table Public - by Country
    • 10.1.2 Chart - Public Growth
  • 10.2 Hospital
    • 10.2.1 Table Hospital - by Country
    • 10.2.2 Chart - Hospital Growth
  • 10.3 Clinic
    • 10.3.1 Table Clinic - by Country
    • 10.3.2 Chart - Clinic Growth
  • 10.4 Workplace
    • 10.4.1 Table Workplace - by Country
    • 10.4.2 Chart - Workplace Growth
  • 10.5 DTC/OTC
    • 10.5.1 Table DTC/OTC - by Country
    • 10.5.2 Chart - DTC/OTC Growth
  • 10.6 Wastewater
    • 10.6.1 Table Wastewater - by Country
    • 10.6.2 Chart - Wastewater Growth

11 Appendix

  • 11.1 U.S., Europe, Asia Approved COVID-19 Assays

Table of Tables

  • Table 1 Who List of Potential Pandemic Pathogens
  • Table 2 Characteristics of Coronavirus Pandemic Infections
  • Table 3 COVID-19 Symptoms
  • Table 4 Market Players by Type
  • Table 5 Global Market by Region
  • Table 6 Global Market by Technology
  • Table 7 Global Market by Product
  • Table 8 Global Market by Channel
  • Table 9 PCR by Country
  • Table 10 PCR Multiplex by Country
  • Table 11 Sequencing by Country
  • Table 12 Antibody by Country
  • Table 13 Antigen by Country
  • Table 14 Instruments by Country
  • Table 15 Reagents & Kits by Country
  • Table 16 Extraction by Country
  • Table 17 Collection by Country
  • Table 18 Public by Country
  • Table 19 Hospital by Country
  • Table 20 Clinic by Country
  • Table 21 Workplace by Country
  • Table 22 DTC/OTC by Country
  • Table 23 Wastewater by Country
  • Table 24 Approved Covid-19 Assays

Table of Figures

  • Figure 1 Global Distribution Pandemic Preparedness
  • Figure 2 Global Pandemic Pathogen Status
  • Figure 3 Estimated Economic Impact of Viral Pandemic by Region
  • Figure 4 Historical Pandemics Infographic
  • Figure 5 Antigenic Drift Creates a new Strain of Virus
  • Figure 6 Structure of Coronaviruses
  • Figure 7 The Road to Diagnostics
  • Figure 8 Global Market Share Chart
  • Figure 9 Base/Final Year Comparison Chart
  • Figure 10 Global Markets by Technology Base Year
  • Figure 11 Global Markets by Technology End Year
  • Figure 12 Global Markets by Technology Share by Year
  • Figure 13 Global Markets by Technology Segment Growth
  • Figure 14 Global Market by Product Base vs. Final
  • Figure 15 Global Market by Product Base Year
  • Figure 16 Global Market by Product End Year
  • Figure 17 Global Market by Product Share by Year
  • Figure 18 Global Market by Product Segments Growth
  • Figure 19 Global Market by Channel - Base vs. Final
  • Figure 20 Global Market by Channel - Base Year
  • Figure 21 Global Market by Channel - End Year
  • Figure 22 Global Market by Channel - Share by Year
  • Figure 23 Global Market by Channel - Segments Growth
  • Figure 24 PCR Growth
  • Figure 25 PCR Multiplex Growth
  • Figure 26 Sequencing Growth
  • Figure 27 Antibody Growth
  • Figure 28 Antigen Growth
  • Figure 29 Instruments Growth
  • Figure 30 Reagents & Kits Growth
  • Figure 31 Extraction Growth
  • Figure 32 Collection Growth
  • Figure 33 Public Growth
  • Figure 34 Hospital Growth
  • Figure 35 Clinic Growth
  • Figure 36 Workplace Growth
  • Figure 37 DTC/OTC Growth
  • Figure 38 Wastewater Growth